Literature DB >> 34718934

Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature.

Antonio Marzollo1,2, Francesca Conti3, Andrea Finocchi4,5, Silvia Bresolin6, Linda Rossini7, Beatrice Rivalta4,5, Lucia Leonardi8, Caterina Tretti6, Francesca Tosato9, Maria Chiriaco5, Giorgiana Madalina Ursu5, Cristina Tea Natalucci7, Maddalena Martella7, Alessandro Borghesi10,11, Cecilia Mancini12, Andrea Ciolfi12, Gigliola di Matteo4,5, Marco Tartaglia12, Caterina Cancrini4,5, Andrea Dotta13, Alessandra Biffi6.   

Abstract

Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI), characterized by a deficient phagocyte killing due to the inability of NADPH oxidase to produce reactive oxygen species in the phagosome. Patients with CGD suffer from severe and recurrent infections and chronic inflammatory disorders. Onset of CGD has been rarely reported in neonates and only as single case reports or small case series. We report here the cases of three newborns from two different kindreds, presenting with novel infectious and inflammatory phenotypes associated with CGD. A girl with CYBA deficiency presented with necrotizing pneumonia, requiring a prolonged antibiotic treatment and resulting in fibrotic pulmonary changes. From the second kindred, the first of two brothers developed a fatal Burkholderia multivorans sepsis and died at 24 days of life. His younger brother had a diagnosis of CYBB deficiency and presented with Macrophage Activation Syndrome/Hemophagocytic Lympho-Histiocytosis (MAS/HLH) without any infection, that could be controlled with steroids. We further report the findings of a review of the literature and show that the spectrum of microorganisms causing infections in neonates with CGD is similar to that of older patients, but the clinical manifestations are more diverse, especially those related to the inflammatory syndromes. Our findings extend the spectrum of the clinical presentation of CGD to include unusual neonatal phenotypes. The recognition of the very early, potentially life-threatening manifestations of CGD is crucial for a prompt diagnosis, improvement of survival and reduction of the risk of long-term sequelae.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CGD; CYBA; CYBB; HLH; MAS; Necrotizing pneumonia; Newborn

Mesh:

Year:  2021        PMID: 34718934     DOI: 10.1007/s10875-021-01159-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  40 in total

Review 1.  Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.

Authors:  Maria Chiriaco; Irene Salfa; Gigliola Di Matteo; Paolo Rossi; Andrea Finocchi
Journal:  Pediatr Allergy Immunol       Date:  2016-01-21       Impact factor: 6.377

2.  Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease.

Authors:  Aristóteles Álvarez-Cardona; Ana Luisa Rodríguez-Lozano; Lizbeth Blancas-Galicia; Francisco Eduardo Rivas-Larrauri; Marco A Yamazaki-Nakashimada
Journal:  J Clin Immunol       Date:  2011-11-26       Impact factor: 8.317

3.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

4.  Common severe infections in chronic granulomatous disease.

Authors:  Beatriz E Marciano; Christine Spalding; Alan Fitzgerald; Daphne Mann; Thomas Brown; Sharon Osgood; Lynne Yockey; Dirk N Darnell; Lisa Barnhart; Janine Daub; Lisa Boris; Amy P Rump; Victoria L Anderson; Carissa Haney; Douglas B Kuhns; Sergio D Rosenzweig; Corin Kelly; Adrian Zelazny; Tamika Mason; Suk See DeRavin; Elizabeth Kang; John I Gallin; Harry L Malech; Kenneth N Olivier; Gulbu Uzel; Alexandra F Freeman; Theo Heller; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

5.  Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

Authors:  J Liese; S Kloos; V Jendrossek; T Petropoulou; U Wintergerst; G Notheis; M Gahr; B H Belohradsky
Journal:  J Pediatr       Date:  2000-11       Impact factor: 4.406

6.  Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden.

Authors:  A Ahlin; M De Boer; D Roos; J Leusen; C I Smith; U Sundin; H Rabbani; J Palmblad; G Elinder
Journal:  Acta Paediatr       Date:  1995-12       Impact factor: 2.299

7.  Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.

Authors:  Baldassarre Martire; Roberto Rondelli; Annarosa Soresina; Claudio Pignata; Teresa Broccoletti; Andrea Finocchi; Paolo Rossi; Marco Gattorno; Marco Rabusin; Chiara Azzari; Rosa M Dellepiane; Maria C Pietrogrande; Antonino Trizzino; Paolo Di Bartolomeo; Silvana Martino; Luigi Carpino; Fausto Cossu; Franco Locatelli; Rita Maccario; Paolo Pierani; Maria C Putti; Achille Stabile; Luigi D Notarangelo; Alberto G Ugazio; Alessandro Plebani; Domenico De Mattia
Journal:  Clin Immunol       Date:  2007-11-26       Impact factor: 3.969

8.  Twenty-year follow-up of esophageal involvement in chronic granulomatous disease.

Authors:  Heather L Laskey; Lakshmi Gopal; John I Gallin; Steven M Holland; Theo Heller
Journal:  Am J Gastroenterol       Date:  2009-09       Impact factor: 10.864

9.  EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease.

Authors:  David C Thomas; Louis-Marie Charbonnier; Andrea Schejtman; Hasan Aldhekri; Eve L Coomber; Elizabeth R Dufficy; Anne E Beenken; James C Lee; Simon Clare; Anneliese O Speak; Adrian J Thrasher; Giorgia Santilli; Hamoud Al-Mousa; Fowzan S Alkuraya; Talal A Chatila; Kenneth G C Smith
Journal:  J Allergy Clin Immunol       Date:  2018-10-09       Impact factor: 10.793

Review 10.  Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.

Authors:  Ang Wei; Honghao Ma; Liping Zhang; Zhigang Li; Qing Zhang; Dong Wang; Li Zhang; Hongyun Lian; Rui Zhang; Tianyou Wang
Journal:  BMC Pediatr       Date:  2020-03-03       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.